drugs compete with Proscar (finasteride) for benign prostatic hyperplasia
December 2002
You will eventually see drugs compete with Proscar (finasteride) for benign prostatic hyperplasia.
For example, Avodart (dutasteride) is under consideration by Health Canada. It's similar to Proscar, but it blocks both types of 5 alpha-reductase. Proscar selectively blocks only type 2.
By blocking both type 1 and type 2, Avodart appears to lower dihydrotestosterone levels more than Proscar.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote